Vancouver Health World Partners Earn $500 - $1,500 per day. Passive Income Ideas. Coronavirus Vaccine Jobs.

 Healthcare & Pharmaceuticals
Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market
COVID-19 vaccine market booms; Pfizer, Moderna to gain billions
Pfizer, Moderna seen making billions from COVID-19 vaccine boosters
Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster market

NEW YORK, Aug 13 (Reuters) - Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts and healthcare investors say.



For several months, the companies have said they expect that fully inoculated people will need an extra dose of their vaccines to maintain protection over time and to fend off new coronavirus variants.

Now a growing list of governments, including Chile, Germany and Israel, have decided to offer booster doses to older citizens or people with weak immune systems in the face of the fast-spreading Delta variant.

Send an email to:  dreamfundingworld@gmail.com



World Drug Market
Become a partner and earn $500 - $1,500 today as a partner.  (Limited space)
Share your dream business idea. Get sponsored today and receive up to $350,000 in funding.
Reply to emails and ad-posting jobs also available .

https://stayintoronto.createmybb4.com/thread-554.html

Thanks

Comments

Post a Comment

Popular posts from this blog

Pfizer, Moderna seen making billions from COVID-19 vaccine boosters

Image
  Pfizer, Moderna seen making billions from COVID-19 vaccine boosters Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken on March 19, 2021. Photo: Reuters. Companies say fully inoculated people may need extra dose of their vaccines to maintain protection over time. Chile, Germany and Israel, have decided to offer booster doses to older citizens. Pfizer, along with its German partner BioNTech, and Moderna have together locked up over $60 billion in sales of the shots just in 2021 and 2022. NEW YORK: Drugmakers Pfizer Inc, BioNTech, and Moderna Inc are expected to make billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts and healthcare investors say. For several months, the companies have said they expect that fully inoculated people will need an extra dose of their vaccines to mainta...
Read more